tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GLSI Stock Latest News

Greenwich LifeSciences expands FLAMINGO-01 clinical trial into Europe
The FlyGreenwich LifeSciences expands FLAMINGO-01 clinical trial into Europe
4d ago
GLSI
Greenwich LifeSciences announces activation of Phase 3 trial in Poland
PremiumThe Fly
Greenwich LifeSciences announces activation of Phase 3 trial in Poland
6d ago
GLSI
Greenwich LifeSciences provides update on commercial manufacturing of GP2
PremiumThe Fly
Greenwich LifeSciences provides update on commercial manufacturing of GP2
11d ago
GLSI
Greenwich LifeSciences partners with GBG in Germany for breast cancer trial
PremiumThe Fly
Greenwich LifeSciences partners with GBG in Germany for breast cancer trial
19d ago
GLSI
Greenwich LifeSciences partners with Unicancer expanding Flamingo-01 into France
PremiumThe Fly
Greenwich LifeSciences partners with Unicancer expanding Flamingo-01 into France
20d ago
GLSI
Greenwich LifeSciences partners with GIM in Italy for breast cancer trial
PremiumThe FlyGreenwich LifeSciences partners with GIM in Italy for breast cancer trial
2M ago
GLSI
Greenwich LifeSciences files $275M mixed securities shelf
Premium
The Fly
Greenwich LifeSciences files $275M mixed securities shelf
4M ago
GLSI
Greenwich LifeSciences price target raised to $38 from $36 at H.C. Wainwright
Premium
The Fly
Greenwich LifeSciences price target raised to $38 from $36 at H.C. Wainwright
5M ago
GLSI
Greenwich LifeSciences provides update on FLAMINGO-01 trial
PremiumThe Fly
Greenwich LifeSciences provides update on FLAMINGO-01 trial
6M ago
GLSI
Greenwich LifeSciences set to join Russell 2000 Index
PremiumThe Fly
Greenwich LifeSciences set to join Russell 2000 Index
7M ago
GLSI
Fly Insider: Occidental, Applied Materials among week’s notable insider trades
PremiumThe Fly
Fly Insider: Occidental, Applied Materials among week’s notable insider trades
7M ago
AGO
AJG
Greenwich LifeSciences to sell 174,825 shares at $14.30 in private placement
PremiumThe Fly
Greenwich LifeSciences to sell 174,825 shares at $14.30 in private placement
8M ago
GLSI
Greenwich LifeSciences extends lock-up of directors and officers
PremiumThe FlyGreenwich LifeSciences extends lock-up of directors and officers
11M ago
GLSI
Greenwich LifeSciences initiates first clinical sites in Europe
Premium
The Fly
Greenwich LifeSciences initiates first clinical sites in Europe
11M ago
GLSI
Greenwich LifeSciences’ Flamingo-01 Phase 3 trial expanding in Europe
Premium
The Fly
Greenwich LifeSciences’ Flamingo-01 Phase 3 trial expanding in Europe
11M ago
GLSI
Greenwich LifeSciences’ Phase 3 trial protocol accepted by European regulators
PremiumThe Fly
Greenwich LifeSciences’ Phase 3 trial protocol accepted by European regulators
12M ago
GLSI
Greenwich LifeSciences price target lowered to $36 from $38 at H.C. Wainwright
PremiumThe Fly
Greenwich LifeSciences price target lowered to $36 from $38 at H.C. Wainwright
12M ago
GLSI
Greenwich LifeSciences Reports Progress in Flamingo-01 Trial
PremiumCompany Announcements
Greenwich LifeSciences Reports Progress in Flamingo-01 Trial
12M ago
8K
GLSI
Greenwich LifeSciences provides update on Phase III clinical trial Flamingo-01
PremiumThe Fly
Greenwich LifeSciences provides update on Phase III clinical trial Flamingo-01
12M ago
GLSI
Greenwich LifeSciences price target lowered to $38 from $78 at H.C. Wainwright
PremiumThe FlyGreenwich LifeSciences price target lowered to $38 from $78 at H.C. Wainwright
2y ago
GLSI
Greenwich LifeSciences provides year-end update
Premium
The Fly
Greenwich LifeSciences provides year-end update
2y ago
GLSI
Greenwich LifeSciences extends lock-up of directors, officers to end of 2023
Premium
The Fly
Greenwich LifeSciences extends lock-up of directors, officers to end of 2023
2y ago
GLSI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >